- Q1 2024 Ligand Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2024€67.5Earnings
- Q4 2023 Ligand Pharmaceuticals Inc Earnings Call TranscriptFeb 27, 2024€78 (+13.87%)Earnings
- Ligand Pharmaceuticals Inc To Host Investor Day TranscriptDec 12, 2023
- Q3 2023 Ligand Pharmaceuticals Inc Earnings Call TranscriptNov 08, 2023€49 (-1.21%)Earnings
- Q2 2023 Ligand Pharmaceuticals Inc Earnings Call TranscriptAug 08, 2023€60 (+0.84%)Earnings
- Q1 2023 Ligand Pharmaceuticals Inc Earnings Call TranscriptMay 04, 2023€68 (+0.74%)Earnings
- Q4 2022 Ligand Pharmaceuticals Inc Earnings Call TranscriptFeb 22, 2023€66.1 (-0.99%)Earnings
- Ligand Pharmaceuticals Inc Investor and Analyst Day TranscriptDec 13, 2022
- Q3 2022 Ligand Pharmaceuticals Inc Earnings Call TranscriptNov 07, 2022€61.94 (-3.04%)Earnings
- Q2 2022 Ligand Pharmaceuticals Inc Earnings Call TranscriptAug 08, 2022€59.17 (-0.04%)Earnings
- Ligand Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 10, 2022
- Q1 2022 Ligand Pharmaceuticals Inc Earnings Call TranscriptMay 04, 2022€55.04 (-2.91%)Earnings
- Q4 2021 Ligand Pharmaceuticals Inc Earnings Call TranscriptFeb 17, 2022€66.74 (-0.84%)Earnings
- Q3 2021 Ligand Pharmaceuticals Inc Earnings Call TranscriptNov 09, 2021€81.37 (-1.18%)Earnings
- Q2 2021 Ligand Pharmaceuticals Inc Earnings Call TranscriptJul 29, 2021€64.68 (+1.67%)Earnings
- Ligand Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 04, 2021
- Q1 2021 Ligand Pharmaceuticals Inc Earnings Call TranscriptMay 03, 2021€74.06 (-1.90%)Earnings
- Q4 2020 Ligand Pharmaceuticals Inc Earnings Call TranscriptFeb 03, 2021€93.16 (+2.79%)Earnings
- Ligand Pharmaceuticals Inc Extraordinary Shareholders Meeting TranscriptDec 15, 2020
- Q3 2020 Ligand Pharmaceuticals Inc Earnings Call TranscriptOct 30, 2020€43.76 (-11.93%)Earnings
- Ligand Pharmaceuticals Inc Virtual Investor Day TranscriptOct 20, 2020
- Q2 2020 Ligand Pharmaceuticals Inc Earnings Call TranscriptAug 03, 2020€63.74 (+2.32%)Earnings
- Ligand Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 10, 2020
- Q1 2020 Ligand Pharmaceuticals Inc Earnings Call TranscriptMay 06, 2020€57.38 (+3.26%)Earnings
- Ligand Pharmaceuticals Inc at Barclays Global Healthcare Conference TranscriptMar 10, 2020
- Q4 2019 Ligand Pharmaceuticals Inc Earnings Call TranscriptFeb 06, 2020€52.52 (+0.60%)Earnings
- Q3 2019 Ligand Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2019€63.15Earnings
- Q2 2019 Ligand Pharmaceuticals Inc Earnings Call TranscriptJul 30, 2019€59.9 (-1.37%)Earnings
- Q1 2019 Ligand Pharmaceuticals Inc Earnings Call TranscriptMay 02, 2019€69.76 (-0.18%)Earnings
- Ligand Pharmaceuticals Inc at Barclays Global Healthcare Conference TranscriptMar 13, 2019
- Ligand Pharmaceuticals Inc Analyst Day TranscriptMar 12, 2019
- Ligand Pharmaceuticals Inc Announce Sale of Promacta Assets and Royalty to Royalty Pharma Call TranscriptMar 05, 2019
- Q4 2018 Ligand Pharmaceuticals Inc Earnings Call TranscriptFeb 07, 2019€63.24 (-2.09%)Earnings
Ligand Pharmaceuticals Inc To Host Investor Day Transcript
Okay. I think we're going to get started. My name is Bob Yedid. I'm a Managing Director at LifeSci Advisors. Happy to be working with Ligand. We're delighted that all of you are here today, both in person as well as on the webcast. We planned the full agenda for you and the CEO, Todd Davis, sitting right here, is going to be basically starting off today. If you could save your questions to the end, there will be a Q&A session. And for those who are basically on the webcast, you'll be able to submit your questions in the basic question box on the online call manager.
Before we begin, there will be slides that we're using to guide our discussions. Today, we'll be using non-GAAP financial measures and some of the statements will be forward looking. We'll have a Q&A session to conclude our formal remarks, as I mentioned. Additional information regarding the risks and other matters concerning Ligand could be found in Ligand's summary press release that will be issued later today, along with slides associated with this call, and our periodic
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)